nib Group reported a 6.2% revenue increase to $3.8 billion and a 9.1% rise in underlying operating profit to $260.9 million for FY26, despite a 5.9% net profit dip. The company achieved maiden profitability in Health Services and declared a fully franked 21c dividend including a 5c special, supported by ongoing Travel insurance divestments.
- 6.2% revenue growth to $3.8 billion
- Underlying operating profit up 9.1% to $260.9 million
- Net profit after tax down 5.9% to $186.9 million
- Health Services division turns profitable for first time
- Board declares 21c fully franked dividend including 5c special
Strong underlying profit growth offsets net profit dip
nib holdings limited (ASX:NHF) has reported a solid FY26 financial performance, with underlying operating profit (UOP) climbing 9.1% to $260.9 million on the back of 6.2% revenue growth to $3.8 billion. However, net profit after tax (NPAT) declined 5.9% to $186.9 million, reflecting lower investment income and higher tax expense. The company’s balance sheet strengthened notably, with debt reduced by $71.8 million to $204.8 million, lowering the gearing ratio to 15.2% from 20.1% a year earlier.
This result was achieved amid ongoing cost-of-living pressures and elevated healthcare claims inflation, which nib managed through disciplined pricing and productivity initiatives that delivered $61 million in value during the year. The operating expense ratio improved by 110 basis points to 16.6%, driven by automation and AI adoption across claims and customer service functions.
Australian residents health insurance remains core
The Australian residents health insurance (arhi) business, which covers more than 1.4 million policyholders, remains the Group’s largest contributor with $3.0 billion in insurance revenue, up 6.4%. Underlying operating profit in this segment fell 9.6% to $187.9 million due to elevated claims inflation of 4.1% (4.5% including NSW bed rate changes) and a higher lapse rate of 16.2%, partly driven by portfolio repositioning and competitive pressures. Policyholder growth was a disciplined 1.9%, broadly in line with industry trends.
nib’s hospital contracting program and expanded First Choice provider network helped customers save $57 million in out-of-pocket costs, supporting a stable net margin in the 6-7% target range. Customer advocacy remained strong with a net promoter score (NPS) of +32, and 94.8% of claims processed within 24 hours, with 86.3% processed through automation.
Adjacent businesses gain momentum
Adjacent businesses contributed $86.1 million in underlying operating profit, up $41.9 million, now accounting for roughly one third of Group earnings. The international inbound health insurance business grew UOP 15.1% to $35.1 million, supported by 4.4% policyholder growth across the Pacific Australia Labour Mobility scheme and skilled worker segments, alongside a high NPS of +62.
nib New Zealand delivered a strong turnaround, returning to profitability with $27.5 million UOP compared to a $2.9 million loss in FY25. This was achieved through deliberate pricing actions, claims recovery initiatives, and expense discipline, despite a decline in policyholders by 7.7%. Customer advocacy improved markedly in the second half, with NPS rising from +2 to +25.
Health Services, including Honeysuckle Health and ItsMyGroup, reached profitability for the first time with a $2.4 million underlying operating profit. Health management program enrolments increased to over 18,500, with external member satisfaction at +91.3. nib Thrive, the Group’s National Disability Insurance Scheme plan management business, contributed $16.3 million UOP, navigating a challenging regulatory environment while improving participant retention and operational efficiency.
Travel insurance divestment progresses
nib has finalised the strategic review of its travel insurance business and announced sales of both the World Nomads international business and the Australian/New Zealand travel insurance operations to SiriusPoint and Allianz Partners respectively. These transactions are expected to complete in the first half of FY27, unlocking an estimated $97 million in net proceeds. nib will continue distributing travel insurance products through a long-term partnership with Allianz Partners, transitioning to a capital-light distribution model.
The sale proceeds have already supported a special dividend of 5 cents per share declared alongside the ordinary dividend, bringing the full year dividend to 34 cents per share, fully franked. The Board has increased the target dividend payout ratio to 65-75%, reflecting confidence in the Group’s cash flow and capital position.
Outlook and strategic priorities for FY27
Looking ahead, nib targets underlying operating profit growth to $265 million to $285 million, excluding the Travel business, subject to risk equalisation outcomes. The company plans to continue delivering productivity gains through digital and AI initiatives, further improve the operating expense ratio, and maintain disciplined capital allocation.
Growth priorities include sustainable, high-quality policyholder growth in the Australian residents business with margins maintained within the 6-7% target range, ongoing strong contributions from international and New Zealand segments, and positive momentum in Health and Insurance Services. nib Thrive is positioned to benefit from expected NDIS reforms favouring scaled, compliant plan managers.
The company also remains focused on claims management, provider partnerships, and enhancing customer value and affordability amid a dynamic regulatory environment. The expected receipt of Travel sale proceeds provides additional balance sheet flexibility and capital management optionality.
Governance and remuneration updates
FY26 saw director changes with the retirement of Donal O’Dwyer and appointment of Hisham El-Ansary, bringing deep healthcare and insurance experience. The remuneration report highlights disciplined execution with the Managing Director’s short-term incentive awarded at 95.6% of target and long-term incentive vesting at 29.31%, reflecting performance against total shareholder return and earnings per share hurdles.
nib continues to embed risk culture and accountability into its remuneration framework, linking pay outcomes to sustainable performance, conduct, and customer outcomes. The company has also strengthened its climate risk governance and sustainability disclosures, with no material financial impact identified from climate-related risks in FY26.
With a clearer strategic focus, improved operating efficiency, and a stronger balance sheet, nib is positioned to navigate ongoing challenges in healthcare inflation, affordability, and regulatory change while delivering value to customers and shareholders alike.
Bottom Line?
nib’s FY26 results show resilience through disciplined growth and productivity gains, but upcoming regulatory and market shifts, especially post-Travel divestment, will test its strategic execution.
Questions in the middle?
- How will nib manage margin pressure amid ongoing claims inflation and regulatory reforms?
- What impact will the Travel insurance divestment have on nib’s long-term growth and capital allocation?
- Can nib’s Health Services and nib Thrive segments sustain profitability and scale in a changing healthcare landscape?